Deferred Tax Assets, Operating Loss Carryforwards of China SXT Pharmaceuticals, Inc. from 31 Mar 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
China SXT Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Mar 2020 to 31 Mar 2025.
  • China SXT Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Mar 2025 was $901,032, a 0.5% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $901,032 -$4,542 -0.5% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q3 2024 $931,731 +$278,746 +43% 30 Sep 2024 6-K 28 Mar 2025 2025 Q2
Q1 2024 $905,574 +$352,746 +64% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q3 2023 $652,985 +$213,818 +49% 30 Sep 2023 6-K 05 Apr 2024 2024 Q2
Q1 2023 $552,828 +$160,720 +41% 31 Mar 2023 20-F 13 Aug 2024 2024 FY
Q3 2022 $439,167 30 Sep 2022 6-K 24 Feb 2023 2023 Q2
Q1 2022 $392,108 +$292,013 +292% 31 Mar 2022 20-F 31 Jul 2023 2023 FY
Q1 2021 $100,095 +$9,661 +11% 31 Mar 2021 20-F/A 19 May 2023 2022 FY
Q1 2020 $90,434 31 Mar 2020 20-F 13 Aug 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.